Table 4.
Best responses by tumor type
| BCC (n = 33) | Medulloblastoma (n = 1) | Other solid tumors (n = 34) | |
|---|---|---|---|
| Complete response | 2a | 0 | 0 |
| Partial response | 17a | 1b | 0 |
| Stable disease | 10a | 0 | 4 |
| Progressive disease | 4 | 0 | 24 |
| Missingc | 0 | 0 | 6c |
a
Both complete responses were assessed clinically; 8 partial responses were assessed clinically, 8 by RECIST, and 1 by both clinical and RECIST.
b
Unconfirmed RECIST partial response.
c
Patients who experienced clinical progression or withdrew from study before tumor assessments could be performed.